Sign in
Taking people in United StatesNo phase

Text Messages to Help Adolescents and Adults Take Oral Leukemia Chemotherapy

Tests text message reminders to support taking oral chemotherapy in leukemia and lymphoma patients.

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Registry title
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Status
Recruiting
People taking part
48 people, planned
Started
19 May 2026
Expected to end
15 Jun 2028
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • High Intensity
  • No Text Messagings
  • Low Intensity Text Messaging
Record updated
10 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 15 or older with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma who take oral chemotherapy. It tests whether text messages help them take it.

Age
15 years or older
Sex
All sexes can join.
Disease stage
Diagnosed with ALL or T-cell lymphoblastic lymphoma, being treated with a regimen that includes a maintenance phase.
Earlier treatment
Currently treated with a pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (for example CALGB 10403). Enrollment is before maintenance starts. In the pilot phase, people may have started maintenance if it ends after the 28-day pilot intervention.

Main reasons for not taking part

  • The patient or caregiver who would get the text messages has no cell phone that receives text messages
  • The patient does not wish to take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Age of 15 years or older at time of enrollment
  • Diagnosed with ALL or T-cell lymphoblastic lymphoma
  • Currently receiving treatment with pediatric-based regimen that includes maintenance with mercaptopurine and methotrexate (e.g., CALGB 10403). Study participation begins with the start of maintenance, so enrollment occurs prior to the start of maintenance. Patients in the pilot phase may have already started maintenance as long as the end of their maintenance therapy is scheduled to occur after the end of the 28-day pilot intervention

Who cannot take part

  • Patient or caregiver who would receive text message reminders does not have a cell phone that receives text messages
  • Patient does not wish to participate
  • Text messages will be crafted in the patient's preferred language for medical communication, so English fluency is not an enrollment requirement

Where in United States

  • University of Chicago Medicine-Comprehensive Cancer CenterChicago, United StatesContact: Clinical Trials IntakeTaking people

About the trial

What the trial wants to find out

This is a single center 2-phase study to assess effects of using text messages on adherence to oral chemotherapy for patients with acute lymphoblastic leukemia (ALL) or T-cell lymphoblastic lymphoma.

The 3 groups in the trial

  • Efficacy Phase: High Intensity MessagingExisting treatment, for comparison

    Receives high-intensity text messaging for 2 cycles of treatment

    Treatment: High Intensity

  • Efficacy Phase: Low Intensity MessagingExisting treatment, for comparison

    Receives no texts for 1st cycle and low-intensity texts for 2nd cycle

    Treatment: No Text Messagings and Low Intensity Text Messaging

  • Pilot Phase ArmTreatment being tested

    Participants receive high-intensity text messaging for 28 days

    Treatment: High Intensity

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Improving Oral Chemotherapy Adherence in Maintenance for Adolescents and Adults With Acute Lymphoblastic Leukemia and T-cell Lymphoblastic Lymphoma Using Text Messages
Plain-language title
Text Messages to Help Adolescents and Adults Take Oral Leukemia ChemotherapyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
10 July 2026